Univariate and multivariate prognostic predictors
| Variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | |
| Age | 1.02 (0.99–1.04) | 0.09 | ||
| Male sex | 1.80 (1.04–3.10) | 0.03 | ||
| BMI ≥ 30 | 1.51 (0.89–2.55) | 0.12 | ||
| Diabetes mellitus | 1.62 (1.00–2.62) | 0.05 | ||
| Arterial hypertension | 1.46 (0.87–2.45) | 0.15 | ||
| Hypercholesterolemia | 1.02 (0.63–1.63) | 0.94 | ||
| Current smoker | 1.04 (0.60–1.82) | 0.88 | ||
| Left bundle branch block | 0.54 (0.13–2.20) | 0.39 | ||
| Permanent atrial fibrillation | 4.81 (2.46–9.40) | < 0.0001 | 2.90 (1.38–6.07) | 0.005 |
| Paced rhythm | 1.44 (0.45–4.58) | 0.54 | ||
| Prior myocardial infarction | 2.07 (1.25–3.41) | 0.005 | ||
| Prior CABG | 1.62 (0.51–5.15) | 0.41 | ||
| Prior PCI | 1.45 (0.88–2.39) | 0.15 | ||
| β-Blocker therapy | 1.14 (0.71–1.84) | 0.58 | ||
| LVEDV | 1.01 (1.00–1.02) | 0.005 | ||
| LVESV | 1.01 (1.00–1.02) | 0.006 | ||
| SBP/LVES volume | 0.90 (0.79–1.04) | 0.15 | ||
| LVEF < 50% | 1.87 (1.03–3.42) | 0.04 | ||
| B-lines ≥ 2 | 2.45 (1.52–3.96) | < 0.0001 | 1.76 (1.05–2.97) | 0.03 |
| GLS ≤ 16.2% | 2.69 (1.66–4.36) | < 0.0001 | 2.00 (1.17–3.45) | 0.01 |
